Kymera Therapeutics, Inc. (KYMR) SEC Filings — 2024
27 SEC filings for Kymera Therapeutics, Inc. (KYMR) in 2024.
Filings
- Kymera Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Kymera Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Kymera Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Kymera Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 12, 2024
- Kymera Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Kymera Therapeutics Files Q3 2024 10-Q — 10-Q · Oct 31, 2024
- Baker Bros. Advisors Amends Kymera Therapeutics Stake — SC 13D/A · Aug 22, 2024
- Kymera Therapeutics Enters Material Definitive Agreement — 8-K · Aug 20, 2024
- Kymera Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Kymera Therapeutics Files 8-K — 8-K · Jul 8, 2024
- Kymera Therapeutics Files 8-K on Officer/Director Changes — 8-K · Jun 20, 2024
- Kymera Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Kymera Therapeutics, Inc. DEF 14A Filing — DEF 14A · Apr 24, 2024
- Kymera Therapeutics Appoints New CMO, Adds Directors — 8-K · Apr 1, 2024
- Baker Bros. Advisors reports 10.6% stake in Kymera Therapeutics — SC 13D · Apr 1, 2024
- Kymera Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
- Kymera Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Kymera Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- T. Rowe Price Maintains 9.6% Stake in Kymera Therapeutics — SC 13G/A · Feb 12, 2024
- Atlas Venture Fund X Amends Kymera Therapeutics Stake — SC 13G/A · Feb 9, 2024
- Wellington Management Group LLP Amends Kymera Therapeutics Stake — SC 13G/A · Feb 8, 2024
- BlackRock Amends Kymera Therapeutics Stake, Remains Passive Investor — SC 13G/A · Jan 29, 2024
- State Street Corp. Updates Passive Stake in Kymera Therapeutics — SC 13G/A · Jan 23, 2024
- Baker Bros. Advisors LP Amends Kymera Therapeutics Stake — SC 13G/A · Jan 10, 2024
- BVF Partners Amends Kymera Therapeutics Stake, Signals Ownership Shift — SC 13D/A · Jan 9, 2024
- Kymera Therapeutics Reports Material Agreement, Financial Condition Changes — 8-K · Jan 5, 2024
- Kymera to Present at J.P. Morgan Healthcare Conference Jan 9 — 8-K · Jan 4, 2024